Source:http://linkedlifedata.com/resource/pubmed/id/12902494
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-8-6
|
pubmed:abstractText |
mAb HC-10 loses its reactivity with HLA class I (HLA-I) H chain (HC) following its association with beta(2)-microglobulin (beta(2)m). Furthermore, the HC-10 defined epitope appears to be involved in the pathogenesis of spondyloarthropathies, because HC-10 reduced their incidence in HLA-B27(+)beta(2)m degrees /MHC class II knockout mice. This study has characterized the determinant recognized by HC-10. Panning of a phage display peptide library with HC-10 resulted in isolation of the motif PxxWDR, which could be aligned with P57, W60, D61, and R62 of the first domain of the HLA-I HC allospecificities reactive with HC-10. The (55)EGPEYWDR(N/E)T(64) (p-1) is the shortest motif-bearing peptide that reacts with HC-10 and inhibits its binding to soluble HLA-B7 HC, irrespective of whether N (p-1a) or E (p-1b) is present at position 63. By contrast, HC-10 did not react with six additional peptides, each bearing motif amino acid substitutions present in HC-10-not-reactive HLA-I allospecificities. The p-1-derived Qp-1, synthesized with the additional conserved Q54, which displays the highest in vitro reactivity with HC-10, was the only one to induce in mice IgG resembling HC-10 in their fine specificity. Mapping of the HC-10-defined determinant suggests that the lack of mAb reactivity with beta(2)m-associated HLA-I HC is caused by blocking by the peptide in the groove of beta(2)m-associated HLA-I HC, though a role of HC conformational changes following its association with beta(2)m cannot be excluded. This information contributes to our understanding of the molecular basis of the antigenic profiles of beta(2)m-free and beta(2)m-associated HLA-I HC and may serve to develop active specific immunotherapy of spondyloarthropathies.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/HLA Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class I,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Subunits,
http://linkedlifedata.com/resource/pubmed/chemical/beta 2-Microglobulin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
171
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1918-26
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12902494-Amino Acid Motifs,
pubmed-meshheading:12902494-Animals,
pubmed-meshheading:12902494-Antibodies, Monoclonal,
pubmed-meshheading:12902494-Antibody Specificity,
pubmed-meshheading:12902494-Bacteriophage M13,
pubmed-meshheading:12902494-Binding, Competitive,
pubmed-meshheading:12902494-Binding Sites, Antibody,
pubmed-meshheading:12902494-Cell Line,
pubmed-meshheading:12902494-Computer Simulation,
pubmed-meshheading:12902494-Epitope Mapping,
pubmed-meshheading:12902494-Female,
pubmed-meshheading:12902494-HLA Antigens,
pubmed-meshheading:12902494-Histocompatibility Antigens Class I,
pubmed-meshheading:12902494-Humans,
pubmed-meshheading:12902494-Injections, Intraperitoneal,
pubmed-meshheading:12902494-Mice,
pubmed-meshheading:12902494-Mice, Inbred BALB C,
pubmed-meshheading:12902494-Models, Molecular,
pubmed-meshheading:12902494-Molecular Mimicry,
pubmed-meshheading:12902494-Peptide Fragments,
pubmed-meshheading:12902494-Protein Binding,
pubmed-meshheading:12902494-Protein Subunits,
pubmed-meshheading:12902494-Tumor Cells, Cultured,
pubmed-meshheading:12902494-beta 2-Microglobulin
|
pubmed:year |
2003
|
pubmed:articleTitle |
Beta 2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide.
|
pubmed:affiliation |
Department of Biomedical Sciences and Human Oncology, Section of Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|